Genetically determined oxidation polymorphism and drug hepatotoxicity

This publication has 16 references indexed in Scilit:

• Metoprolol-lnduced Hepatitis: Rechallenge and Drug Oxidation Phenotyping
  Annals of Internal Medicine, 1988
• Polymorphism of dextromethorphan oxidation in a French population.
  British Journal of Clinical Pharmacology, 1987
• Genetically determined polymorphisms in drug oxidation
  Hepatology, 1986
• Enzymatic activation of chemicals to toxic metabolites
  CRC Critical Reviews in Toxicology, 1985
• Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
  Gut, 1984
• DEXTROMETHORPHANAS A SAFE PROBE FOR DEBRISOQUINE HYDROXYLATION POLYMORPHISM
  The Lancet, 1984
• Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism
  Biochemistry, 1984
• Inherited Defects of Hepatic Drug Metabolism
  Seminars in Liver Disease, 1983
• A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.
  Journal of Medical Genetics, 1980
• POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
  The Lancet, 1977